Latest Breaking News On - Josh grieger - Page 1 : comparemela.com

First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure

First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms1GenePHIT is a clinical trial to evaluate the safety and efficacy of the one-time administration of AB-1002 and will include the largest number.

First Patient Randomized In Askbio Phase II Gene Therapy Trial For Congestive Heart Failure

Askbio Contribution To Advancing Gene Therapy Highlighted At ESGCT 30Th Congress

AskBio Contribution to Advancing Gene Therapy Highlighted at ESGCT 30th Congress